This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Lois W. King Lab | |
|---|---|
| Name | Lois W. King Lab |
| Established | 1998 |
| Director | Lois W. King |
| Location | Boston, Massachusetts |
| Institution | unnamed research institute |
| Focus | biomedical and environmental science |
| Staff | ~120 |
Lois W. King Lab is a multidisciplinary research laboratory located in Boston, Massachusetts, affiliated with a private research institute. The laboratory conducts work spanning biomedical engineering, molecular biology, environmental chemistry, and translational medicine, engaging with clinical centers, regulatory agencies, and industrial partners. Its personnel include principal investigators, postdoctoral fellows, and technical staff who collaborate on basic science and applied projects.
Founded in 1998 during a period of expansion in biotechnology, the laboratory developed alongside institutions such as Harvard University, Massachusetts Institute of Technology, Boston University, Brigham and Women's Hospital, and Massachusetts General Hospital. Early collaborations linked the lab to initiatives led by figures associated with the Human Genome Project, the National Institutes of Health, and the Howard Hughes Medical Institute. During the 2000s the lab expanded its scope in response to programs from the National Science Foundation, grants modeled on awards from the Gates Foundation and partnerships inspired by networks like the Broad Institute. In the 2010s the lab participated in consortia connected to the Boston Biomedical Innovation Center, engaged with regulatory frameworks from the Food and Drug Administration, and contributed to regional efforts alongside MassBio and the Life Sciences Center at the University of Massachusetts. Recent years have seen interaction with global initiatives such as projects aligned with the World Health Organization and collaborations echoing the structure of Wellcome Trust-funded research.
The lab pursues an interdisciplinary agenda including translational research in immunology, synthetic biology, environmental monitoring, and biomaterials. Projects intersect with paradigms championed by leaders like James Watson, Craig Venter, Jennifer Doudna, and Emmanuelle Charpentier through work on nucleic-acid technologies and genome editing. The molecular biology portfolio references methodologies associated with the Sanger sequencing era and next-generation platforms developed by entities such as Illumina and Pacific Biosciences. In immunoengineering, the lab's approaches parallel themes from studies by Carl June, Rita Levi-Montalcini, and Anthony Fauci. Environmental sensing projects draw inspiration from programs at NOAA, Environmental Protection Agency, and research institutions like Woods Hole Oceanographic Institution and the Scripps Institution of Oceanography. The lab also addresses translational pipelines resembling efforts at Johns Hopkins University, Stanford University, University of California, San Francisco, and Yale University.
The laboratory houses equipment aligned with core facilities found at major research centers: high-throughput sequencers analogous to those by Illumina and Oxford Nanopore Technologies, mass spectrometers related to platforms from Thermo Fisher Scientific, confocal microscopes comparable to products by Leica Microsystems and Zeiss, and flow cytometers in the style of BD Biosciences. It maintains biocontainment suites reflecting standards from the Centers for Disease Control and Prevention and imaging suites used by teams at Memorial Sloan Kettering Cancer Center and Dana–Farber Cancer Institute. Computational infrastructure supports analyses using pipelines influenced by projects at European Bioinformatics Institute, National Center for Biotechnology Information, and software ecosystems from Google, Amazon Web Services, and Microsoft Research.
The lab's collaborations span academic, clinical, governmental, and industrial partners, including ties with universities such as Harvard University, MIT, Columbia University, Princeton University, and Brown University. Clinical partnerships mirror interactions with Brigham and Women's Hospital, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, and regional health systems modeled on Kaiser Permanente. Industrial and startup engagements reflect relationships similar to those between research labs and companies such as Moderna, Pfizer, Novartis, Roche, and Johnson & Johnson. The lab participates in consortia and advisory groups akin to panels run by the National Institutes of Health, collaborates with nonprofits like the Bill & Melinda Gates Foundation and Elizabeth Glaser Pediatric AIDS Foundation, and contributes to initiatives coordinated by networks such as the Broad Institute and the Koch Institute for Integrative Cancer Research.
Key projects have included development of diagnostic assays paralleling work published in journals like Nature, Science, Cell, The Lancet, and Proceedings of the National Academy of Sciences. Noteworthy efforts involve assay platforms comparable to those advanced by Craig Venter-era teams, CRISPR-related studies in the spirit of Jennifer Doudna and Emmanuelle Charpentier, and environmental monitoring projects resembling collaborations with NOAA and Woods Hole Oceanographic Institution. Publications from the lab appear in venues associated with editorial boards like those of Nature Medicine, Science Translational Medicine, and PNAS, and include contributions to conferences similar to the American Association for the Advancement of Science meetings, the Biophysical Society symposia, and the Synthetic Biology: Engineering, Evolution & Design forum.
Funding streams combine competitive awards from agencies comparable to the National Institutes of Health, the National Science Foundation, and philanthropic grants patterned after those from the Wellcome Trust and the Gates Foundation. The administrative model echoes governance structures found at academic centers such as Harvard University and MIT with oversight resembling offices in large hospitals like Massachusetts General Hospital. Intellectual property management follows practices used by technology transfer offices at institutions like Stanford University and Columbia University, and compliance frameworks align with standards set by the Institutional Review Board processes and the Food and Drug Administration.
Category:Research laboratories